BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 23490884)

  • 21. The poly(ADP-Ribose) polymerase inhibitor ABT-888 reduces radiation-induced nuclear EGFR and augments head and neck tumor response to radiotherapy.
    Nowsheen S; Bonner JA; Yang ES
    Radiother Oncol; 2011 Jun; 99(3):331-8. PubMed ID: 21719137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overcoming radioresistance in head and neck squamous cell carcinoma.
    Yamamoto VN; Thylur DS; Bauschard M; Schmale I; Sinha UK
    Oral Oncol; 2016 Dec; 63():44-51. PubMed ID: 27938999
    [TBL] [Abstract][Full Text] [Related]  

  • 23. G2-checkpoint targeting and radiosensitization of HPV/p16-positive HNSCC cells through the inhibition of Chk1 and Wee1.
    Busch CJ; Kröger MS; Jensen J; Kriegs M; Gatzemeier F; Petersen C; Münscher A; Rothkamm K; Rieckmann T
    Radiother Oncol; 2017 Feb; 122(2):260-266. PubMed ID: 27939202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiation Enhancement of Head and Neck Squamous Cell Carcinoma by the Dual PI3K/mTOR Inhibitor PF-05212384.
    Leiker AJ; DeGraff W; Choudhuri R; Sowers AL; Thetford A; Cook JA; Van Waes C; Mitchell JB
    Clin Cancer Res; 2015 Jun; 21(12):2792-801. PubMed ID: 25724523
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of the EGFR with nanoparticles encapsulating antisense oligonucleotides of the EGFR enhances radiosensitivity in SCCVII cells.
    Ping Y; Jian Z; Yi Z; Huoyu Z; Feng L; Yuqiong Y; Shixi L
    Med Oncol; 2010 Sep; 27(3):715-21. PubMed ID: 19653138
    [TBL] [Abstract][Full Text] [Related]  

  • 26. STAT3 blockade with shRNA enhances radiosensitivity in Hep-2 human laryngeal squamous carcinoma cells.
    Li X; Wang H; Lu X; Di B
    Oncol Rep; 2010 Feb; 23(2):345-53. PubMed ID: 20043094
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of radiation response after epidermal growth factor receptor blockade in squamous cell carcinomas: inhibition of damage repair, cell cycle kinetics, and tumor angiogenesis.
    Huang SM; Harari PM
    Clin Cancer Res; 2000 Jun; 6(6):2166-74. PubMed ID: 10873065
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radio-sensitization of head and neck cancer cells by a combination of poly(I:C) and cisplatin through downregulation of survivin and c-IAP2.
    Mikulandra M; Kobescak A; Verillaud B; Busson P; Matijevic Glavan T
    Cell Oncol (Dordr); 2019 Feb; 42(1):29-40. PubMed ID: 30182341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CDK4/6 Inhibitor LEE011 Is a Potential Radiation-sensitizer in Head and Neck Squamous Cell Carcinoma: An
    Tai TS; Lin PM; Wu CF; Hung SK; Huang CI; Wang CC; Su YC
    Anticancer Res; 2019 Feb; 39(2):713-720. PubMed ID: 30711949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Linifanib (ABT-869) Potentiates the Efficacy of Chemotherapeutic Agents through the Suppression of Receptor Tyrosine Kinase-Mediated AKT/mTOR Signaling Pathways in Gastric Cancer.
    Chen J; Guo J; Chen Z; Wang J; Liu M; Pang X
    Sci Rep; 2016 Jul; 6():29382. PubMed ID: 27387652
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preferential targeting of cancer stem cells in the radiosensitizing effect of ABT-737 on HNSCC.
    Gilormini M; Malesys C; Armandy E; Manas P; Guy JB; Magné N; Rodriguez-Lafrasse C; Ardail D
    Oncotarget; 2016 Mar; 7(13):16731-44. PubMed ID: 26934442
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination of salinomycin and radiation effectively eliminates head and neck squamous cell carcinoma cells in vitro.
    Gehrke T; Hackenberg S; Polat B; Wohlleben G; Hagen R; Kleinsasser N; Scherzad A
    Oncol Rep; 2018 Apr; 39(4):1991-1998. PubMed ID: 29436675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Curcumin potentiates laryngeal squamous carcinoma radiosensitivity via NF-ΚB inhibition by suppressing IKKγ expression.
    Deng XZ; Geng SS; Luo M; Chai JJ; Xu Y; Chen CL; Qiu L; Ke Q; Duan QW; Song SM; Shen L; Luo ZG
    J Recept Signal Transduct Res; 2020 Dec; 40(6):541-549. PubMed ID: 32515250
    [No Abstract]   [Full Text] [Related]  

  • 34. Taselisib (GDC-0032), a Potent β-Sparing Small Molecule Inhibitor of PI3K, Radiosensitizes Head and Neck Squamous Carcinomas Containing Activating PIK3CA Alterations.
    Zumsteg ZS; Morse N; Krigsfeld G; Gupta G; Higginson DS; Lee NY; Morris L; Ganly I; Shiao SL; Powell SN; Chung CH; Scaltriti M; Baselga J
    Clin Cancer Res; 2016 Apr; 22(8):2009-19. PubMed ID: 26589432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monoterpenes enhanced the sensitivity of head and neck cancer cells to radiation treatment in vitro.
    Samaila D; Toy BJ; Wang RC; Elegbede JA
    Anticancer Res; 2004; 24(5A):3089-95. PubMed ID: 15517920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated RET expression enhances EGFR activation and mediates EGFR inhibitor resistance in head and neck squamous cell carcinoma.
    Lin C; Lu W; Ren Z; Tang Y; Zhang C; Yang R; Chen Y; Cao W; Wang L; Wang X; Ji T
    Cancer Lett; 2016 Jul; 377(1):1-10. PubMed ID: 27090738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multikinase inhibitors sorafenib and sunitinib as radiosensitizers in head and neck cancer cell lines.
    Affolter A; Samosny G; Heimes AS; Schneider J; Weichert W; Stenzinger A; Sommer K; Jensen A; Mayer A; Brenner W; Mann WJ; Brieger J
    Head Neck; 2017 Apr; 39(4):623-632. PubMed ID: 28221700
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhancement of radiosensitivity in head and neck cancer cells by ZD1839 ('IRESSA'), a selective epidermal growth factor receptor tyrosine kinase inhibitor.
    Shintani S; Kiyota A; Mihara M; Sumida T; Kayahara H; Nakashiro K; Hamakawa H
    Am J Clin Oncol; 2003 Oct; 26(5):e150-6. PubMed ID: 14528090
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel multi-targeted tyrosine kinase inhibitor, linifanib (ABT-869), produces functional and structural changes in tumor vasculature in an orthotopic rat glioma model.
    Luo Y; Jiang F; Cole TB; Hradil VP; Reuter D; Chakravartty A; Albert DH; Davidsen SK; Cox BF; McKeegan EM; Fox GB
    Cancer Chemother Pharmacol; 2012 Apr; 69(4):911-21. PubMed ID: 22080168
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of STAT-3 results in greater cetuximab sensitivity in head and neck squamous cell carcinoma.
    Bonner JA; Yang ES; Trummell HQ; Nowsheen S; Willey CD; Raisch KP
    Radiother Oncol; 2011 Jun; 99(3):339-43. PubMed ID: 21704410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.